Health
Dartmouth TB vaccine moves one step closer to a full Phase 3 efficacy trial – News-Medical.Net
Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine were announced today by investigators at Dartmouth’s Geisel School of Medicine and publi…
Reviewed by Emily Henderson, B.Sc.Sep 29 2020
Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine were announced today by investigators at Dartmouth’s Geisel School of Medicine and published in the journal Vaccine. The three-year trial was conducted among 650 adolescents in Tanzania, a nation with high rates of TB infection, and showed that the vaccine was safe and induced immune responses against the disease.
Tuberculosis is most common infectious disease cause of death in…
-
General11 hours agoVolodymyr Zelenskyy claims Chinese soldiers fighting alongside Russians in Ukraine
-
General17 hours agoHow what happens on financial markets affects the broader economy
-
Noosa News17 hours agoParents warned to be on alert as risk increases for Japanese Encephalitis this school holidays
-
Noosa News21 hours agoFound property, Kawana Waters – Sunshine Coast